Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.43
-0.30 (-2.15%)
At close: Mar 28, 2025, 4:00 PM
13.62
+0.19 (1.43%)
After-hours: Mar 28, 2025, 7:59 PM EDT

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $342.39 million. The enterprise value is $264.24 million.

Market Cap 342.39M
Enterprise Value 264.24M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

BNTC has 25.49 million shares outstanding. The number of shares has increased by 451.89% in one year.

Current Share Class 25.49M
Shares Outstanding 25.49M
Shares Change (YoY) +451.89%
Shares Change (QoQ) +107.39%
Owned by Insiders (%) 5.94%
Owned by Institutions (%) 36.42%
Float 22.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.15
P/TBV Ratio 4.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 25.48, with a Debt / Equity ratio of 0.00.

Current Ratio 25.48
Quick Ratio 25.34
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -46.85% and return on invested capital (ROIC) is -32.74%.

Return on Equity (ROE) -46.85%
Return on Assets (ROA) -29.99%
Return on Invested Capital (ROIC) -32.74%
Return on Capital Employed (ROCE) -31.71%
Revenue Per Employee n/a
Profits Per Employee -$1.34M
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +161.79% in the last 52 weeks. The beta is 0.92, so BNTC's price volatility has been similar to the market average.

Beta (5Y) 0.92
52-Week Price Change +161.79%
50-Day Moving Average 12.25
200-Day Moving Average 10.35
Relative Strength Index (RSI) 48.65
Average Volume (20 Days) 56,676

Short Selling Information

Short Interest 216,131
Short Previous Month 174,803
Short % of Shares Out 0.85%
Short % of Float 0.98%
Short Ratio (days to cover) 1.35

Income Statement

Revenue n/a
Gross Profit 3,000
Operating Income -24.09M
Pretax Income -21.69M
Net Income -21.42M
EBITDA -24.00M
EBIT -24.09M
Earnings Per Share (EPS) -$1.94
Full Income Statement

Balance Sheet

The company has $78.28 million in cash and $137,000 in debt, giving a net cash position of $78.15 million or $3.07 per share.

Cash & Cash Equivalents 78.28M
Total Debt 137,000
Net Cash 78.15M
Net Cash Per Share $3.07
Equity (Book Value) 75.94M
Book Value Per Share 3.24
Working Capital 75.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.75 million and capital expenditures -$191,000, giving a free cash flow of -$21.94 million.

Operating Cash Flow -21.75M
Capital Expenditures -191,000
Free Cash Flow -21.94M
FCF Per Share -$0.86
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -451.89%
Shareholder Yield n/a
Earnings Yield -6.25%
FCF Yield -6.41%
Dividend Details

Analyst Forecast

The average price target for BNTC is $24.43, which is 81.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target $24.43
Price Target Difference 81.91%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date Jul 26, 2023
Split Type Reverse
Split Ratio 0.0588235:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1